Ensign Peak Advisors’s Ocugen OCGN Stock Holding History

Ensign Peak Advisors’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-54,570	Closed	-$248K	–	2237
2021 Q4	$248K	Buy	+54,570	New	+$412K	﹤0.01%	1876

Other funds holding OCGN

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ensign Peak Advisors's OCGN Position: Q1 2022 in Review

Ensign Peak Advisors sold out of Ocugen (OCGN) in Q1 2022, closing a stake of 54,570 shares — an estimated $248K sold.

Ensign Peak Advisors first reported a position in OCGN in Q4 2021 and held it in 1 quarter. The position peaked at $248K in Q4 2021. 122 funds tracked by Wall St. Rank hold OCGN as of Q1 2022.

Ensign Peak Advisors reported no remaining Ocugen position as of Q1 2022 after selling out during the quarter.
Ensign Peak Advisors sold 54,570 Ocugen shares in Q1 2022, an estimated $248K.
Ensign Peak Advisors first reported a position in Ocugen in Q4 2021 and held it in 1 quarter.
Ensign Peak Advisors's Ocugen position peaked at $248K in Q4 2021.
122 funds tracked by Wall St. Rank held Ocugen as of Q1 2022.

Based on Ensign Peak Advisors's 13F filing for Q1 2022, filed 16 May 2022.